2019/1. Evaluation
The evaluation is in progress. The complete evaluations are continually uploaded to the I-QC. The Certificates of Participation are available on the I-QC as well.
8 Şubat 2019
The EQAST Serology EQA programme is designed to monitor the performance of tests used to detect HIV/Hepatitis virus antibodies,Syphilis. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative qualitative methods of analysis.
2 lyophilized or liquid samples. Brief case histories also given. Fresh blood is needed in the specimen preparation. The samples intended for susceptibility testing may include both international quality control strains and susceptible or resistant clinical strains. Culture, identification, antimicrobial susceptibility.
The EQAST Brucella EQA programme is designed to monitor the performance of tests used to detect Brucella Tests.
EQAST provide EQA for laboratories providing clinical diagnostic bacteriology services in determining antifungal susceptibilities in clinically significant yeasts and filamentous fungi, antimicrobial susceptibilities in various genera of microorganisms,
The EQAST General Clinical Chemistry EQA programme is designed to monitor the performance of up to 60 parameters covering routine chemistries, lipids, hormones Specific Proteins and trace metals. Three flexible yet cost effective programme options are available.
the EQAST Coagulation EQA programme is designed to monitor the performance of 5 routine coagulation tests
The EQAST Urinalysis EQA programme is designed to monitor the performance of urine dipstick test using both manual and automated methods. All samples are supplied in a liquid ready-to-use format ideal for both clinical and point-of-care testing (POCT).
The RIQAS Immunoassay EQA programme is designed to monitor the performance of up to 55 immunoassay parameters including therapeutic drugs; hormones and tumour markers. Four flexible and cost effective programme options are available.
The EQAST Cardiac EQA programme is designed to monitor the performance of up to 9 clinically significant cardiac markers.
The EQAST Rapid Tests/Manuel Tests EQA programme is designed to monitor the performance of up to 9 different clinically significant tests. Participants can register separately
The EQAST, PCT EQA programme is designed to monitor the performance of clinically significant test.
Ethanol in a single EQAST programme and samples are supplied liquid ready-to-use samples liquid or Lyophilised for enhanced stability
The EQAST, Anti CCP EQA programme is designed to monitor the performance of clinically significant test.
Liquid or Lyophilised for enhanced stability
The EQAST, D-Dimer EQA programme is designed to monitor the performance of clinically significant test.
The evaluation is in progress. The complete evaluations are continually uploaded to the I-QC. The Certificates of Participation are available on the I-QC as well.
Shipping date: 29 June 2019 Deadline of the reporting of the results: 13 June 2019 Please, mind the deadline!
Shipping date: 29 January 2019 Deadline of the reporting of the results: 13 February 2019 Please, mind the deadline!
2019 © EQAST Quality Control Assesment System | All Rights Reserved
Etiam magna arcu, ullamcorper ut pulvinar et, ornare sit amet ligula. Aliquam vitae bibendum lorem. Cras id dui lectus. Pellentesque nec felis tristique urna lacinia sollicitudin ac ac ex. Maecenas mattis faucibus condimentum. Curabitur imperdiet felis at est posuere bibendum. Sed quis nulla tellus.
63739 street lorem ipsum City, Country
+12 (0) 345 678 9
info@company.com